These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6245654)

  • 1. Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes.
    Smolen JE; Weissmann G
    Biochem Pharmacol; 1980 Feb; 29(4):533-8. PubMed ID: 6245654
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysosomal enzyme release from human granulocytes is inhibited by indomethacin, ETYA, and BPB.
    Smolen JE; Weissmann G
    Adv Prostaglandin Thromboxane Res; 1980; 8():1695-700. PubMed ID: 6246788
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible role of arachidonic acid and of phospholipase A2 in the control of lysosomal enzyme release from human polymorphonuclear leukocytes.
    Marone G; Fimiani B; Torella G; Poto S; Bianco P; Condorelli M
    J Clin Lab Immunol; 1983 Oct; 12(2):111-6. PubMed ID: 6644791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control mechanisms of histamine release from human basophils in vitro: the role of phospholipase A2 and of lipoxygenase metabolites.
    Marone G; Kagey-Sobotka A; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():144-8. PubMed ID: 6171522
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of neutrophil activation by p-bromophenacyl bromide and its effects on phospholipase A2.
    Duque RE; Fantone JC; Kramer C; Marasco WA; Phan SH
    Br J Pharmacol; 1986 Jun; 88(2):463-72. PubMed ID: 3015312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the human polymorphonuclear leukocyte inflammatory response by inhibitors of arachidonic acid metabolism.
    Yocum DE; Hempel S; Busse WW
    J Immunopharmacol; 1984; 6(4):237-55. PubMed ID: 6098611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neutrophil phospholipase A2 by p-bromophenylacyl bromide, nordihydroguaiaretic acid, 5,8,11,14-eicosatetraynoic acid and quercetin.
    Lanni C; Becker EL
    Int Arch Allergy Appl Immunol; 1985; 76(3):214-7. PubMed ID: 3972457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the neutrophil oxidative response to a chemotactic peptide by inhibitors of arachidonic acid oxygenation.
    Bokoch GM; Reed PW
    Biochem Biophys Res Commun; 1979 Sep; 90(2):481-7. PubMed ID: 508315
    [No Abstract]   [Full Text] [Related]  

  • 9. Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase.
    Henderson LM; Chappell JB; Jones OT
    Biochem J; 1989 Nov; 264(1):249-55. PubMed ID: 2557829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane mediates neutrophil superoxide production in pregnancy.
    Vaughan JE; Walsh SW; Ford GD
    Am J Obstet Gynecol; 2006 Nov; 195(5):1415-20. PubMed ID: 16643813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the incorporation of [1-14C]arachidonic acid into glycerolipids and its conversion into prostaglandins by rabbit iris. Effects of anti-inflammatory drugs and phospholipase A2 inhibitors.
    Abdel-Latif AA; Smith JP
    Biochim Biophys Acta; 1982 Jun; 711(3):478-89. PubMed ID: 6809058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism.
    Lee TP; Matteliano ML; Middleton E
    Life Sci; 1982 Dec; 31(24):2765-74. PubMed ID: 6818414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production.
    Goldstein IM; Lind S; Hoffstein S; Weissmann G
    J Exp Med; 1977 Aug; 146(2):483-94. PubMed ID: 195003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities.
    Cerletti C; Livio M; Doni MG; De Gaetano G
    Biochim Biophys Acta; 1983 Aug; 759(1-2):125-7. PubMed ID: 6411131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase A2 inhibitors. Differential inhibition of fatty acid acylation into kidney lipids by mepacrine and p-bromophenacyl bromide.
    Erman A; Azuri R; Raz A
    Biochem Pharmacol; 1983 Jul; 32(13):2083-7. PubMed ID: 6870935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cis-Polyunsaturated fatty acids induce high levels of superoxide production by human neutrophils.
    Badwey JA; Curnutte JT; Karnovsky ML
    J Biol Chem; 1981 Dec; 256(24):12640-3. PubMed ID: 6273400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial kinetics of lysosomal enzyme secretion and superoxide anion generation by human polymorphonuclear leukocytes.
    Smolen JE; Korchak HM; Weissmann G
    Inflammation; 1980 Jun; 4(2):145-63. PubMed ID: 6248464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsaturated fatty acids as second messengers of superoxide generation by macrophages.
    Bromberg Y; Pick E
    Cell Immunol; 1983 Jul; 79(2):240-52. PubMed ID: 6307532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids.
    Bomalaski JS; Baker DG; Brophy L; Resurreccion NV; Spilberg I; Muniain M; Clark MA
    J Immunol; 1989 Jun; 142(11):3957-62. PubMed ID: 2541202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls.
    Tithof PK; Schiamberg E; Peters-Golden M; Ganey PE
    Environ Health Perspect; 1996 Jan; 104(1):52-8. PubMed ID: 8834862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.